| Structural insights into SARS-CoV-2 proteins R Arya, S Kumari, B Pandey, H Mistry, SC Bihani, A Das, V Prashar, ... Journal of molecular biology 433 (2), 166725, 2021 | 405 | 2021 |
| Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs R Arya, A Das, V Prashar, M Kumar | 147 | 2020 |
| Evaluating stability and activity of SARS-CoV-2 PLpro for high-throughput screening of inhibitors R Arya, V Prashar, M Kumar Molecular Biotechnology, 1-8, 2022 | 15 | 2022 |
| Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs. 2020 R Arya, A Das, V Prashar, M Kumar ChemRxiv Preprint, 2020 | 7 | 2020 |
| Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs.[Academic Search] R Arya, A Das, V Prashar, M Kumar | 6 | 2020 |
| Insights into the evolution of mutations in SARS-CoV-2 non-spike proteins R Arya, P Tripathi, K Nayak, J Ganesh, SC Bihani, B Ghosh, V Prashar, ... Microbial Pathogenesis 185, 106460, 2023 | 3 | 2023 |
| Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro R Arya, V Prashar, M Kumar International Journal of Biological Macromolecules 230, 123347, 2023 | 1 | 2023 |
| Identification of Novel Inhibitor of SARS-CoV-2 Plpro R Arya, J Ganesh, V Prashar, M Kumar BARC newsletter, 2024 | | 2024 |
| Characterization of novel potential inhibitor of SARS-CoV-2 PLpro R Arya, V Prashar, M Kumar Journal of Radiation and Cancer Research (Print) 13 (4), 217, 2022 | | 2022 |
| Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs. ChemRxiv. 2020 R Arya, A Das, V Prashar, M Kumar Preprint. https://doi. org/10.26434/chemrxiv 11860011, v2, 0 | | |